Trivascular Lands $60,000,000 Series D Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cce75b5c-5596-479c-a8e1-8d53fbb8d04e&Preview=1 -
Date
6/5/2012 -
Company Name
Trivascular -
Mailing Address
3910 Brickway Blvd Santa Rosa, CA 95403 -
Company Description
Trivascular is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA). -
Website
http://www.trivascular2.com -
Transaction Type
Venture Equity -
Transaction Amount
$60,000,000 -
Transaction Round
Series D -
Proceeds Purposes
Proceeds from the financing will be used to pursue U.S. PMA approval of the Ovation Abdominal Stent Graft System, drive further sales expansion internationally, fuel product development efforts and initiate U.S. commercial activity. -
M&A Terms
-
Venture Investor
Kaiser Permanente Ventures -
Venture Investor
New Enterprise Associates -
Venture Investor
Redmile Group -
Venture Investor
Delphi Ventures -
Venture Investor
MPM Capital -
Venture Investor
Kearny Venture Partners -
Venture Investor
Pinnacle Ventures
